Abstract
Purpose
Taste and smell disturbances in patients affected by cancer are very common, but often under-recognized symptoms. If not addressed properly, they may impact nutritional status, food enjoyment, and quality of life. Treatment tools available for clinicians to manage chemosensory alterations are limited and are often based on personal clinical experiences. The aim of this study was to assess current oncological and palliative care literature through a scoping review, in order to identify available treatments for taste and smell alterations in cancer patients.
Methods
Medline, Embase, CINAHL, ProQuest Dissertations and Theses, and Google Scholar were searched from inception until January 2020, with subject headings relevant to the domains of chemosensory alterations, palliative, and cancer care. A total of 10,718 English and French language publications were reviewed, yielding 43 articles on the researched topic.
Results
The heterogeneity of selected articles led to difficulties in interpretation and analysis of the available evidence. Included publications differed in study design, population sample, anticancer treatments, and measures of assessment for taste and smell disturbances. A broad variety of treatment options were described including zinc and polaprezinc, radio-protectors, vitamins and supplements, anti-xerostomia agents, active swallowing exercises, nutritional interventions, delta-9-tetrahydrocannabinol, and photobiomodulation.
Conclusion
This scoping review identifies the current state of knowledge regarding chemosensory alterations within supportive cancer care. Despite not reaching firm conclusions, this article offers therapeutic venues to further explore in larger and more methodologically sound studies.
Similar content being viewed by others
References
Spotten LE, Corish CA, Lorton CM, Ui Dhuibhir PM, O’Donoghue NC, O’Connor B, Walsh TD (2017) Subjective and objective taste and smell changes in cancer. Ann Onc 28(5):969–984
Gamper EM, Zabernigg A, Wintner LM, Giesinger JM, Oberguggenberger A, Kemmler G, Sperner-Unterweger B, Holzner B (2012) Coming to your senses: detecting taste and smell alterations in chemotherapy patients. A systematic review. J. Pain Symptom Manag 44(6):880–895
Gill SS, Frew J, Fry A, Adam J, Paleri V, Dobrowsky W, Chatterjee S, Kelly CG (2011) Priorities for the head and neck cancer patient, their companion and members of the multidisciplinary team and decision regret. Clinical Oncology 23(8):518–524
Hutton JL, Baracos VE, Wismer VW (2007) Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and quality of life in patients with advanced cancer. J Pain Symptom Manag 33(2):156–165
Boltong A, Keast R, Aranda S (2012) Experiences and consequences of altered taste, flavour and food hedonics during chemotherapy treatment. Support Care Cancer 20(11):2765–2774
Wrobel BB, Leopold DA (2004) Clinical assessment of patients with smell and taste disorders. Otolaryngol Clin N Am 37(6):1127–1142
Epstein JB, Smutzer G, Doty RL (2016) Understanding the impact of taste changes in oncology care. Support Care Cancer 24(4):1917–1931
Amézaga J, Alfaro B, Rios Y, Larraiox A, Ugartemendia G, Urruticoechea A, Tueros I (2018) Assessing taste and smell alterations in cancer patients undergoing chemotherapy according to treatment. Support Care Cancer 26(12):4077–4086
van der Werf A, Rovithi M, Langius JA, de van der Schueren MA, Verheul HM (2017) Insight in taste alterations during treatment with protein kinase inhibitors. Eur J Cancer 86:125–134
Murtaza B, Hichami A, Khan AS, Ghiringhelli F, Khan NA (2017) Alteration in taste perception in cancer: causes and strategies of treatment. Front Physiol 8:134
Spotten L, Corish C, Lorton C, Dhuibhir PU, O’Donoghue N, O’Connor B, Cunningham M, El Beltagi N, Gillham C, Walsh D (2016) Subjective taste and smell changes in treatment-naive people with solid tumours. Support Care Cancer 24(7):3201–3208
Doty RL, Shah M, Bromley SM (2008) Drug-induced taste disorders. Drug Saf 31(3):199–215
Arksey H, O’Malley L (2005) Scoping studies: towards a methodological framework. Int J Soc 8(1):19–32
Erkurt E, Erkisi M, Tunali C (2000) Supportive treatment in weight-losing cancer patients due to the additive adverse effects of radiation treatment and/or chemotherapy. J Exp Clin Cancer Res 19(4):431–439
Thorne T, Olson K, Wismer W (2015) A state-of-the-art review of the management and treatment of taste and smell alterations in adult oncology patients. Support Care Cancer 23(9):2843–2851
Ripamonti C, Zecca E, Brunelli C, Fulfaro F, Villa S, Balzarini A, Bombardieri E, Conno FD (1998) A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation. Cancer 82(10):1938–1945
Najafizade N, Hemati S, Gookizade A, Berjis N, Hashemi M, Vejdani S, Ghannadi A, Shahsanaee A, Arbab N (2013) Preventive effects of zinc sulfate on taste alterations in patients under irradiation for head and neck cancers: a randomized placebo-controlled trial. J Res Med Sci 18(2):123–126
Yamagata T, Nakamura Y, Yamagata Y, Nakanishi M, Matsunaga K, Nakanishi H, Nishimoto T, Minakata Y, Mune M, Yukawa S (2003) The pilot trial of the prevention of the increase in electrical taste thresholds by zinc containing fluid infusion during chemotherapy to treat primary lung cancer. J Exp Clin Cancer Res 22(4):557–563
Silverman JE (1983) Zinc supplementation and taste in head and neck cancer patients undergoing radiation therapy. J Oral Med 38:14–16
Silverman S Jr, Thompson JS (1984) Serum zinc and copper in oral/oropharyngeal carcinoma. A study of seventy-five patients. Oral Surg Oral Med Oral Pathol 57(1):34–36
Khan AH, Safdar J, Siddiqui SU (2019) Efficacy of zinc sulfate on concurrent chemoradiotherapy induced taste alterations in oral cancer patients: a double blind randomized controlled trial. Pak J Med Sci 35(3):624–629
Halyard MY, Jatoi A, Sloan JA, Bearden JD III, Vora SA, Atherton PJ, Perez EA, Soori G, Zalduendo AC, Zhu A, Stella PJ (2007) Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4). Int J Radiat Oncol Biol Phys 67(5):1318–1322
Lyckholm L, Heddinger SP, Parker G, Coyne PJ, Ramakrishnan V, Smith TJ, Henkin RI (2012) A randomized, placebo-controlled trial of oral zinc for chemotherapy-related taste and smell disorders. J Pain Palliat Care Pharmacother 26(2):111–114
Fujii H, Hirose C, Ishihara M, Iihara H, Imai H, Tanaka Y, Matsuhashi N, Takahashi T, Yamaguchi K, Yoshida K, Suzuki A (2018) Improvement of dysgeusia by polaprezinc, a zinc-L-carnosine, in outpatients receiving cancer chemotherapy. Anticancer Res 38(11):6367–6373
Watanabe T, Ishihara M, Matsuura K, Mizuta K, Itoh Y (2010) Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer. Int J Cancer 127(8):1984–1990
Hayashi H, Kobayashi R, Suzuki A, Ishihara M, Nakamura N, Kitagawa J, Kanemura N, Kasahara S, Kitaichi K, Hara T, Tsurumi H (2014) Polaprezinc prevents oral mucositis in patients treated with high-dose chemotherapy followed by hematopoietic stem cell transplantation. Anticancer Res 34(12):7271–7277
Büntzel J, Riesenbeck D, Glatzel M, Berndt-Skorka R, Riedel T, Mücke R, Kisters K, Schönekaes KG, Schäfer U, Bruns F, Micke O (2010) Limited effects of selenium substitution in the prevention of radiation-associated toxicities. Results of a randomized study in head and neck cancer patients. Anticancer Res 30(5):1829–1832
Büntzel J, Schuth J, Küttner K, Glatzel (1998) Radiochemotherapy with amifostine cytoprotection for head and neck cancer. Support Care Cancer 6(2):155–160
Büntzel J, Glatzel M, Muecke R, Micke O, Bruns F (2007) Influence of amifostine on late radiation-toxicity in head and neck cancer-a follow-up study. Anticancer Res 27(4A):1953–1956
Brisbois TD, De Kock IH, Watanabe SM, Mirhosseini M, Lamoureux DC, Chasen M, MacDonald N, Baracos VE, Wismer WV (2011) Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial. Ann Oncol 22(9):2086–2093
Strasser F, Demmer R, Böhme C, Schmitz SFH, Thuerlimann B, Cerny T, Gillessen S (2008) Prevention of docetaxel- or paclitaxel-associated taste alterations in cancer patients with oral glutamine: a randomized, placebo-controlled, double-blind study. Oncologist 13(3):337–346
Wang A, Duncan SE, Lesser GJ, Ray WK, Dietrich AM (2018) Effect of lactoferrin on taste and smell abnormalities induced by chemotherapy: a proteome analysis. Food Funct 9(9):4948–4958
Pattison R (1999) Alteration in taste perception and its relationship with nutritional status and quality of life in patients with advanced cancer. Dissertation, The Open University
Andersson G, Johansson G, Attström R, Edwardsson S, Glantz PO, Larsson K (1995) Comparison of the effect of the linseed extract Salinum® and a methyl cellulose preparation on the symptoms of dry mouth. Gerodontology 12(1):12–17
Jordan WO, Duckert A, Borberg SK, Trog D, Wildfang I (2012) Management of xerostomia with artificial saliva (Xerotin). Eur Arch Oto-Rhino-L 269(4):1384
Nakada K, Ishibashi T, Takei T, Hirata K, Shinohara K, Katoh S, Zhao S, Tamaki N, Noguchi Y, Noguchi S (2005) Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer? J. Nucl. Med 46(2):261–266
Banava S, Houshyari M, Safaie T (2015) The effect of casein phosphopeptide amorphous calcium phosphate fluoride paste (CPP-ACPF) on oral and salivary conditions of patients undergoing chemotherapy: a randomized controlled clinical trial. Electron Physician 7(7):1535–1541
Epstein JB, Emerton S, Le ND, Stevenson-Moore P (1999) A double-blind crossover trial of Oral Balance gel and Biotene toothpaste versus placebo in patients with xerostomia following radiation therapy. Oral Oncol 35(2):132–137
Momm F, Volegova-Neher NJ, Schulte-Möntig J, Guttenberger R (2005) Different saliva substitutes for treatment of xerostomia following radiotherapy. A prospective crossover study. Strahlenther Onkol 181(4):231–236
Schuller DE, Stevens P, Clausen KP, Olsen J, Gahbauer R, Martin M (1989) Treatment of radiation side effects with oral pilocarpine. J Surg Oncol 42(4):272–276
Fisher J, Scott C, Scarantino CW, Leveque FG, White RL, Rotman M, Hodson DI, Meredith RF, Foote R, Bachman DG, Lee N (2003) Phase III quality-of-life study results: impact on patients’ quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer-RTOG 97-09. Int J Radiat Oncol Biol Phys 56(3):832–836
Jham BC, Chen H, Carvalho AL, Freire AR (2009) A randomized phase III prospective trial of bethanechol to prevent mucositis, candidiasis, and taste loss in patients with head and neck cancer undergoing radiotherapy: a secondary analysis. J Oral Sci 51(4):565–572
Wilhelm-Buchstab T, Thelen C, Amecke-Mönnighoff F, Schmeel LC, Simon B, Müdder T, Schoroth F, Garbe S, Röhner F, Vornholt S, Schröck A (2019) Pilot study: protective effect on mucosal tissue using dental waterjet and dexpanthenol rinsing solution during radiotherapy in head and neck tumor patients. Oral Cancer 3(3–4):59–67
Mastroianni C, Magnani C, Giannarelli D, Stefanelli MC, Di Cienzo V, Valerioti T, Casale G, Levano M, Castelli M, Altariva R, Palumbo S, De Leo E, Bosso F, Santilli S, Failla A, Fiumara S, Graziani M (2018) Oral care in a sample of patients undergoing palliative care: a prospective single-centre observational study: Igor study. Palliat Med 32(1):45–46
El Mobadder M, Farhat F, El Mobadder W, Nammour S (2019) Photobiomodulation therapy in the treatment of oral mucositis, dysgeusia and oral dryness as side-effects of head and neck radiotherapy in a cancer patient: a case series. Int J Environ Res Public Health 16(22):4505
Morais MO, Martins AF, de Jesus AP, de Sousa Neto SS, da Costa AW, Pereira CH, Oton-Leite AF, de Freitas NM, Leles CR, Mendonça EF (2020) A prospective study on oral adverse effects in head and neck cancer patients submitted to a preventive oral care protocol. Support Care Cancer 3(1):1–11
Carnaby-Mann G, Crary MA, Schmalfuss I, Amdur R (2012) “Pharyngocise”: randomized controlled trial of preventative exercises to maintain muscle structure and swallowing function during head-and-neck chemoradiotherapy. Int J Radiat Oncol Biol Phys 83(1):210–219
Risberg-Berlin B, Karlsson TR, Tuomi L, Finizia C (2014) Effectiveness of olfactory rehabilitation according to a structured protocol with potential of regaining pre-operative levels in laryngectomy patients using nasal airflow-inducing manoeuvre. Eur Arch Oto-Rhino-L 271(5):1113–1119
Von Grundherr J, Koch B, Grimm D, Salchow J, Valentini L, Hummel T, Bokemeyer C, Stein A, Mann J (2019) Impact of taste and smell training on taste disorders during chemotherapy–TasTe trial. Cancer Manag Res 11:4493–4504
Ravasco P, Monteiro-Grillo I, Marques Vidal P, Camilo ME (2005) Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy. Head Neck 27(8):659–668
Rehwaldt M, Wickham R, Purl S, Tariman J, Blendowski C, Shott S, Lappe M (2009) Self-care strategies to cope with taste changes after chemotherapy. Oncol Nurs Forum 36(2):E47–E56
Williams SA, Schreier AM (2004) The effect of education in managing side effects in women receiving chemotherapy for treatment of breast cancer. Oncol Nurs Forum 31(1):E16–E23
Schiffman SS, Sattely-Miller EA, Taylor EL, Graham BG, Landerman LR, Zervakis J, Campagna LK, Cohen HJ, Blackwell S, Garst JL (2007) Combination of flavor enhancement and chemosensory education improves nutritional status in older cancer patients. J Nutr Health Aging 11(5):439–454
Russ JE, DeWys WD (1978) Correction of taste abnormality of malignancy with intravenous hyperalimentation. Arch of Intern Med 138(5):799–800
Wilken MK, Satiroff BA (2012) Pilot study of “miracle fruit” to improve food palatability for patients receiving chemotherapy. Clin J Oncol Nurs 16(5):E173–E177
Cusnir M, Soares H, Schwartz M, Pizzolato J, Ludsky J, Campbell R, Lilenbaum R (2012) Treatment of taste alterations in chemotherapy patients using “miracle fruit”: P1-31. Psycho-Oncology 21:58
Velargo PA, Samant S (2012) Synsepalum dulcificum and varied taste occurring postradiation trial. Otolaryngol Head Neck Surg 147(2_suppl):178
Yanagimoto H, Satoi S, Toyokawa H, Yamamoto T, Hirooka S, Yamao J, Araki H, Matsui Y, Kwon AH (2009) The beneficial effect of active hexose correlated compound (AHCC), a health food component, in patients with pancreatic or biliary tract cancer who underwent chemotherapy. Pancreas. Conference: Joint 40th Anniversary Meeting of American Pancreatic Association and Japan Pancreas Society. 38(8):1063
Ikeda M, Hirai R, Shigihara S, Ikui A (2008) Taste disorders and zinc deficiency. Int J Med Sci 6(3):105–111
Dajani EZ, Klamut MJ (2000) Novel therapeutic approaches to gastric and duodenal ulcers: an update. Expert Opin Investig Drugs 9(7):1537–1544
Arthur JR (2000) The glutathione peroxidases. Cell Mol Life Sci 57(13–14):1825–1835
Savarese DM, Savy G, Vahdat L, Wischmeyer PE, Corey B (2003) Prevention of chemotherapy and radiation toxicity with glutamine. Cancer Treat Rev 29(6):501–513
Heckmann JG, Heckmann SM, Lang CJ, Hummel T (2003) Neurological aspects of taste disorders. Arch Neurol 60(5):667–671
Siqueiros-Cendón T, Arévalo-Gallegos S, Iglesias-Figueroa BF, García-Montoya IA, Salazar-Martínez J, Rascón-Cruz Q (2014) Immunomodulatory effects of lactoferrin. Acta Pharmacol Sin 35(5):557–566
Ömür-Özbek P, Dietrich AM, Duncan SE, Lee Y (2012) Role of lipid oxidation, chelating agents, and antioxidants in metallic flavor development in the oral cavity. J Agric Food Chem 60(9):2274–2280
Wong JM, Kern M (2011) Miracle fruit improves sweetness of a low-calorie dessert without promoting subsequent energy compensation. Appetite 56(1):163–166
Schiffman SS, Graham BG, Sattely-Miller EA, Zervakis J, Welsh-Bohmer K (2002) Taste, smell and neuropsychological performance of individuals at familial risk for Alzheimer’s disease. Neurobiol Aging 23(3):397–404
Acknowledgments
We thank Dr. Robin Cohen for supervision and contribution toward the final version of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendix
Appendix
Rights and permissions
About this article
Cite this article
Sevryugin, O., Kasvis, P., Vigano, M. et al. Taste and smell disturbances in cancer patients: a scoping review of available treatments. Support Care Cancer 29, 49–66 (2021). https://doi.org/10.1007/s00520-020-05609-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-020-05609-4